📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. (2022)

First Author: Menzies SK

Attributed to: Developing a cocktail of enzyme inhibitors to universally treat haemotoxicity caused by snakebite funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.toxcx.2022.100118

PubMed Identifier: 35321116

Publication URI: http://europepmc.org/abstract/MED/35321116

Type: Journal Article/Review

Volume: 14

Parent Publication: Toxicon: X

ISSN: 2590-1710